Clinical trial NCT03046693 - References

Non-arteritic Anterior Ischemic Optic Neuropathy — Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Citation(s)

•   Galletti P, De Rosa M, Cotticelli MG, Morana A, Vaccaro R, Zappia V
  Biochemical rationale for the use of CDPcholine in traumatic brain injury: pharmacokinetics of the orally administered drug. J Neurol Sci. 1991 Jul;103 Suppl:S19-25.
•   Grieb P, Rejdak R
  Pharmacodynamics of citicoline relevant to the treatment of glaucoma. J Neurosci Res. 2002 Jan 15;67(2):143-8. Review.
•   Grieb P
  Neuroprotective properties of citicoline: facts, doubts and unresolved issues. CNS Drugs. 2014 Mar;28(3):185-93. doi: 10.1007/s40263-014-0144-8. Review.
•   Hayreh SS, Zimmerman MB
  Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology. 2008 Feb;115(2):298-305.e2. Epub 2007 Aug 15.
•   Hayreh SS
  Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Surv Ophthalmol. 2010 Jul-Aug;55(4):399-400; author reply 400-1. doi: 10.1016/j.survophthal.2010.03.003.
•   Levin LA
  Axonal loss and neuroprotection in optic neuropathies. Can J Ophthalmol. 2007 Jun;42(3):403-8. Review.
•   Oshitari T, Fujimoto N, Adachi-Usami E
  Citicoline has a protective effect on damaged retinal ganglion cells in mouse culture retina. Neuroreport. 2002 Nov 15;13(16):2109-11.
•   Parisi V, Coppola G, Centofanti M, Oddone F, Angrisani AM, Ziccardi L, Ricci B, Quaranta L, Manni G
  Evidence of the neuroprotective role of citicoline in glaucoma patients. Prog Brain Res. 2008;173:541-54. doi: 10.1016/S0079-6123(08)01137-0.
•   Parisi V, Coppola G, Ziccardi L, Gallinaro G, Falsini B
  Cytidine-5'-diphosphocholine (Citicoline): a pilot study in patients with non-arteritic ischaemic optic neuropathy. Eur J Neurol. 2008 May;15(5):465-74. doi: 10.1111/j.1468-1331.2008.02099.x. Epub 2
•   Parisi V
  Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5'-diphosphocholine (citicoline): a study of 8 years of follow-up. Doc Ophthalmol. 2005 Jan;110(1):91-102.
•   Park CH, Kim YS, Lee HK, Kim YH, Choi MY, Jung DE, Yoo JM, Kang SS, Choi WS, Cho GJ
  Citicoline reduces upregulated clusterin following kainic acid injection in the rat retina. Curr Eye Res. 2007 Dec;32(12):1055-63.
•   Rejdak R, Toczolowski J, Kurkowski J, Kaminski ML, Rejdak K, Stelmasiak Z, Grieb P
  Oral citicoline treatment improves visual pathway function in glaucoma. Med Sci Monit. 2003 Mar;9(3):PI24-8.
•   Rejdak R, Toczolowski J, Solski J, Duma D, Grieb P
  Citicoline treatment increases retinal dopamine content in rabbits. Ophthalmic Res. 2002 May-Jun;34(3):146-9.
•   Schuettauf F, Rejdak R, Thaler S, Bolz S, Lehaci C, Mankowska A, Zarnowski T, Junemann A, Zagorski Z, Zrenner E, Grieb P
  Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat. Exp Eye Res. 2006 Nov;83(5):1128
•   Secades JJ
  Citicoline: pharmacological and clinical review, 2010 update. Rev Neurol. 2011 Mar 14;52 Suppl 2:S1-S62. Review. English, Spanish.
•   Serra I, Alberghina M, Viola M, Mistretta A, Giuffrida AM
  Effect of CDP-choline on the biosynthesis of nucleic acids and proteins in brain regions during hypoxia. Neurochem Res. 1981 Jun;6(6):607-18.
•   Weiss GB
  Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline. Life Sci. 1995;56(9):637-60. Review.

Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) : Pattern Electroretinography Study

Details for clinical trial NCT03046693